Location History:
- Portland, OR (US) (2010 - 2017)
- Husum, WA (US) (2020)
Company Filing History:
2 out of 22 
1 out of 51,907 
Years Active: 2010-2020
Title: Fred E Masarie, Jr: Innovator in Clinical Trial Technologies
Introduction
Fred E Masarie, Jr. is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of clinical trial technologies, holding a total of 3 patents. His work focuses on improving the efficiency and effectiveness of clinical trials through innovative systems and methods.
Latest Patents
One of his latest patents is titled "System and method for clinical trial candidate matching." This invention involves a computer-implemented system that identifies potential clinical trial participants from databases of patient electronic health information. The system analyzes clinical trial requirements and maps them to an interface terminology, which includes key concepts and related additional concepts. The method further includes mapping patient health information to the interface terminology and building queries to find matches.
Another significant patent is "Method and system for concept-based terminology management." This method describes the implementation of an interface terminology comprising unique concepts and descriptions. The process includes storing concepts and descriptions in a database, linking them, and mapping external codes to concepts. This innovative approach enhances the management of terminology in clinical settings.
Career Highlights
Fred has worked with prominent companies such as Intelligent Medical Objects, Inc. and General Electric Company. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical technology sector.
Collaborations
Fred has collaborated with talented individuals in his field, including Amy Yunhsin Wang and Stuart Lopez. Their combined expertise has contributed to the advancement of clinical trial technologies.
Conclusion
Fred E Masarie, Jr. is a distinguished inventor whose work in clinical trial technologies has the potential to transform the way clinical trials are conducted. His innovative patents and collaborations reflect his commitment to improving healthcare through technology.